Skip to content

Effects of Salmon Fishmeal Ex Vivo (FishMeal Ex Vivo)

Health Effects of Salmon Fish Meal - ex Vivo Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04078958
Enrollment
5
Registered
2019-09-06
Start date
2019-10-15
Completion date
2019-11-07
Last updated
2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Disease, Inflammation, Endocrine; Obesity

Brief summary

Diabetes contributes significantly to the burden of disease in Norway and cardiovascular disease is the main cause of mortality. Both lean and fatty fish are shown to have beneficial health effects. In addition to omega-3 fatty acids, fish contain potential health-promoting components such as taurine, vitamin D, vitamin B12, iodine, selenium and more unspecified components such as bioactive peptides. With the expected growth in the aquaculture sector, more protein-rich by-products will become available. The overall aim of this project is to investigate physiological and molecular effects of fish protein in the form of salmon fishmeal compared to whey in a human intervention study with regard to carbohydrate- and fat metabolism, endocrine factors and inflammation. The investigators will include healthy subjects to a randomized controlled cross over study. The subjects will receive a single, oral dose of fishmeal or whey. Blood samples are taken before (fasting) and 30 and 60 minutes after intake. The molecular effects of fishmeal and whey are investigated ex vivo. This is done by incubating human cell lines (i.e hepatocytes, adipocytes, epithelial cells) with fasting and postprandial serum from the participants.

Interventions

DIETARY_SUPPLEMENTSalmon fishmeal

Salmon fishmeal with high protein content

DIETARY_SUPPLEMENTWhey

Whey with high protein content

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Body mass index 18.5-24.9 kg/m2

Exclusion criteria

* Body mass index \<18.5 or \>24.9 kg/m2 * Known diabetes or high blood pressure * Pregnancy or breast feeding * Allergy or intolerance to dairy or fish/fish protein.

Design outcomes

Primary

MeasureTime frameDescription
Changes in the whole genome transciptome in cultured cellsAcute changes from baseline to 30 and/or 60 minutes.Changes in the whole genome transciptome of cultured cells incubated with fasting and postprandial serum from participants receiving whey or fishmeal.

Secondary

MeasureTime frameDescription
Changes in insulin-stimulated glucose uptake in cultured cell linesAcute changes from baseline to 30 and/or 60 minutes.Changes in insulin sensitivity measured as insulin-stimulated glucose uptake of cultured cells incubated with fasting and postprandial serum from participants receiving whey or fishmeal.
Changes in cytokine secretion in cultured cell linesAcute changes from baseline to 30 and/or 60 minutes.Changes in inflammatory and endocrine factors measured as the secretion of single cytokines from cultured cells incubated with fasting and postprandial serum from participants receiving whey or fishmeal. The choice of factors will be guided by the results from the primary endpoint.
Blood concentration of insulinAcute changes from baseline to 30 and 60 minutesBlood concentration of insulin in participants receiving whey or fishmeal.
Blood concentration of glucoseAcute changes from baseline to 30 and 60 minutesBlood concentration of glucose in participants receiving whey or fishmeal.
Changes in histone marks on selected target genes in cultured cell linesAcute changes from baseline to 30 and/or 60 minutes.Changes in histone marks on selected target genes in cultured cells incubated with fasting or postprandial serum from participants receiving whey or fishmeal.
Blood concentration of cholesterolAcute changes from baseline to 30 and 60 minutesBlood concentration of total cholesterol in participants receiving whey or fishmeal.
Markers in blood related to appetiteAcute changes from baseline to 30 and 60 minutesBlood concentration of the appetite hormones, i.e. GLP-1, Leptin and GIP in participants receiving whey or fishmeal.
Markers in blood related to low grade inflammationAcute changes from baseline to 30 and 60 minutesBlood concentration of microCRP in participants receiving whey or fishmeal.
Markers in blood related to digestion of proteinAcute changes from baseline to 30 and/or 60 minutesBlood concentration of amino acids and small peptides in participants receiving whey or fishmeal.
Blood concentration of triglyceridesAcute changes from baseline to 30 and 60 minutesBlood concentration of triglycerides in participants receiving whey or fishmeal.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026